On July 17, Jiuan Medical announced that the company plans to use no more than RMB 100 million (excluding management fees) of its own funds to subscribe for fund shares of Tianjin Lixixingque Venture Capital Partnership Enterprise (Limited Partnership) for financial investment as a limited partner. The total target subscribed capital contribution of the fund is RMB 1 billion, primarily investing in digital technology computer and software technology development enterprises.
